6G3V
Crystal structure of human carbonic anhydrase I in complex with the inhibitor famotidine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-01-27 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.873 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 62.507, 71.369, 121.442 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.000 - 1.690 |
R-factor | 0.2167 |
Rwork | 0.214 |
R-free | 0.26310 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 3lxe |
RMSD bond length | 0.023 |
RMSD bond angle | 2.199 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | REFMAC |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 1.800 |
High resolution limit [Å] | 1.690 | 1.690 |
Rmeas | 0.083 | 0.151 |
Number of reflections | 57352 | 8041 |
<I/σ(I)> | 8.3 | |
Completeness [%] | 93.5 | 82.6 |
Redundancy | 2.75 | 2.2 |
CC(1/2) | 0.990 | 0.370 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 9 | 296 | 28% PEG4000, 0.2 M sodium acetate, Tris 100 mM |